Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01988246

Completed

Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery (PROMISE)

Diabetic Retinopathy
NCT03350737

Completed

Coronary Arteriogenetic Heparinized Exercise (CARHEXA)

Refractory Angina | Chronic Stable Angina
NCT04109872

Unknown

Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.

Mantle Cell Lymphoma
NCT00046735

Completed

Phase 1 Study OF CDC-501 in Patients With Solid Tumors

Neoplasms
NCT01169298

Completed

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

Peripheral T-cell Lymphoma | Adult T-cell Leukemia-Lymphoma
NCT02976194

Unknown

Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy (CyPov)

Polypoidal Choroidal Vasculopathy | Exudative Age-related Macular Degeneration
NCT01827046

Completed

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III (MISTIE-III)

Intracerebral Hemorrhage
NCT02403128

Unknown

Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms

Macular Edema | Retinal Artery Macroaneurysm
NCT01060176

Unknown

Three Dose Regimen of Tranexamic Acid in Cardiac Surgery

Hemostasis
NCT01058759

Terminated

Taxotere-Enoxaparin-(ENOXA)-Study

Non-small Cell Lung Cancer
NCT00872469

Completed

World Maternal Antifibrinolytic Trial (WOMAN)

Postpartum Haemorrhage
NCT00456495

Completed

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

Conjunctival Neoplasms
NCT01949948

Completed

Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke (NOR-TEST)

Ischemic Stroke
NCT01599650

Completed

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion (BRIGHTER)

Branch Retinal Vein Occlusion
NCT00996437

Completed

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) (N)

Proliferative Diabetic Retinopathy | Vitreous Hemorrhage
NCT01840410

Completed

Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.

Choroidal Neovascularization (CNV)
NCT02865304

Unknown

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Breast Cancer | Angiogenesis
NCT00322985

Completed

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

T-cell Lymphoma
NCT02615366

Unknown

Tranexamic Acid for Bleeding in Breast Surgery (TABBS)

Hematoma | Seroma
NCT01269151

Completed

Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD (LucERG)

Age-Related Macular Degeneration | Retinal Function
NCT02342392

Completed

Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study

Pterygium
NCT01965041

Withdrawn

Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy (AVA)

Pattern Dystrophy of Macula
NCT00826618

Completed

Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema

Uveitic Cystoid Macular Edema
NCT02169648

Unknown

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion
NCT00851864

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism
NCT00058994

Completed

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Macular Degeneration | Maculopathy, Age-Related
NCT00681889

Completed

Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)

Corneal Neovascularization
NCT00211315

Completed

Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)

Coat's Disease
NCT00749021

Completed

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Retinal Pigment Epithelial Detachment
NCT00955630

Unknown

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome (IVL for OHS)

Ocular Histoplasmosis Syndrome
NCT00211328

Completed

Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).

Idiopathic Perifoveal Telangiectasia
NCT00346866

Completed

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

AMD
NCT00044057

Completed

A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

Acute Ischemic Stroke
NCT07073469

Not yet recruiting

Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial

Stroke Ischemic
NCT06173245

Completed

Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy

Diabetic Retinopathy | Visual Acuity | Ranibizumab | Subfoveal Choroidal Thickness | Intravitreal
NCT04671160

Unknown

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
NCT01280929

Completed

Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy

High Risk Proliferative Diabetic Retinopathy
NCT00813891

Unknown

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Macular Degeneration | Visual Acuity
NCT00553657

Completed

The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder

Overactive Bladder
NCT03664180

Completed

Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI (RIGHT)

STEMI - ST Elevation Myocardial Infarction
NCT06839339

Not yet recruiting

Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD

Wet Age-related Macular Degeneration (wAMD)
NCT06749223

Recruiting

AQT90 FLEX D-dimer Clinical Sensitivity and Specificity

VTE (Venous Thromboembolism)
NCT06736860

Recruiting

Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography

Trauma Coagulopathy
NCT06428682

Recruiting

Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

Breast Cancer | Blood Loss, Surgical
NCT06251648

Not yet recruiting

Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)

Cancer
NCT06152939

Not yet recruiting

Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy

Left Ventricular Thrombus
NCT05489185

Not yet recruiting

Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients.

Hip Fractures
NCT04178655

Not yet recruiting

Tranexamic Acid Effect on Digit Function Following Primary Repair of Traumatic Digit Flexor Tendon Injuries

Tendon Injury - Hand
NCT02538198

Active, not recruiting

Lenalidomide Maintenance in Plasma Cell Myeloma

Plasma Cell Myeloma
NCT06879353

Completed

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

Ovarian Cancer | Perioperative Blood Loss | Blood Transfusion Events

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations